Co-Founder & CEO

Chief Commercial Officer

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities

Immix Biopharma To Offer And Sell Up To $750 Million In Securities - SEC Filing

Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants

Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

CMC Documentation Specialist

Immix Biopharma is a global leader in relapsed/refractory AL Amyloidosis, and they are seeking a CMC Documentation Specialist to manage the lifecycle of CMC technical documentation supporting clinical development and regulatory submissions. This role ensures accuracy and compliance of documents while coordinating with various teams to meet regulatory expectations.

Director and Vice President Corporate Development

9 Reasons Why Skin Substitutes Are Dangerous To Use For Wound Care In Long-Term Care

6 Key Components For Taking Global Company Culture To The Next Level

Do-it-yourself founder built Gentell into a global wound-care maker

Gentell Acquires ManukaMed

0.3333333432674408

Document Specialist - CMN Collections

Gentell is one of the largest vertically integrated wound care companies in the world, committed to making a positive difference in the quality of life for the injured and chronically ill. They are seeking a Document Specialist to collect signatures on physicians’ orders for durable medical equipment, while maintaining strong relationships with medical staff and ensuring timely processes.

Cmc Documentation Specialist

Cmc Documentation Specialist in united states (1000+)

CMC Documentation Specialist

Document Specialist - CMN Collections